0001363585-13-000016.txt : 20130620
0001363585-13-000016.hdr.sgml : 20130620
20130620160016
ACCESSION NUMBER: 0001363585-13-000016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130618
FILED AS OF DATE: 20130620
DATE AS OF CHANGE: 20130620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CANADA
STATE: A1
ZIP: M5J 2G2
BUSINESS PHONE: 4163642551
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CA
STATE: A1
ZIP: M5J 2G2
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FELLOWS STEPHEN
CENTRAL INDEX KEY: 0001363585
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 13924500
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQUARE
STREET 2: SUITE 202
CITY: TORONTO
STATE: A6
ZIP: M5J 2G2
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2013-06-18
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001363585
FELLOWS STEPHEN
555 RICHMOND STREET WEST, PO BOX 200
SUITE 604
TORONTO
A6
M5V3B1
ONTARIO, CANADA
0
1
0
0
Chief Financial Officer
Common Stock
2013-06-18
4
S
0
2524164
0.0355
D
0
D
The shares sold were acquired by the reporting person on June 6, 2013 upon exercise of options to purchase 2,524,164 shares of the issuer's common stock which were granted by the Board of Directors on March 5, 2013 and June 4, 2013 in lieu of cash payment of deferred compensation. The option grants were effective upon the reporting person's execution of Settlement and Release Agreements with the issuer on April 1, 2013 and June 6, 2013, respectively. The option grants were made pursuant to the terms of the issuer's 2006 stock plan.
Stephen Fellows
2013-06-20